Logo.png
Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
July 15, 2020 09:00 ET | Guardion Health Sciences, Inc.
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 (GLOBE NEWSWIRE) --...
Logo.png
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease
July 08, 2020 08:45 ET | Guardion Health Sciences, Inc.
Patent Application Will Add to Guardion’s Intellectual Property Portfolio San Diego, California, July 08, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Logo.png
Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate Customer
June 30, 2020 05:00 ET | Guardion Health Sciences, Inc.
Fulfills Initial Order of Astramern from Astramune Sdn Bhd, a Subsidiary of Ho Wah Genting Berhad San Diego, California, June 30, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc....
Logo.png
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
January 07, 2020 11:02 ET | Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Logo.png
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
November 14, 2019 07:00 ET | Guardion Health Sciences, Inc.
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...